Mutations in the PP2A regulatory subunit B family genesPPP2R5B,PPP2R5CandPPP2R5Dcause human overgrowth
Authors:
Open Access
- 13 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 24 (17) , 4775-4779
Abstract
Overgrowth syndromes comprise a group of heterogeneous disorders characterised by excessive growth parameters, often in association with intellectual disability. To identify new causes of human overgrowth, we have been undertaking trio-based exome sequencing studies in overgrowth patients and their unaffected parents. Prioritisation of functionally relevant genes with multiple unique de novo mutations revealed four mutations in protein phosphatase 2A (PP2A) regulatory subunit B family genes protein phosphatase 2, regulatory Subunit B’, beta (PPP2R5B); protein phosphatase 2, regulatory Subunit B’, gamma (PPP2R5C); and protein phosphatase 2, regulatory Subunit B’, delta (PPP2R5D). This observation in 3 related genes in 111 individuals with a similar phenotype is greatly in excess of the expected number, as determined from gene-specific de novo mutation rates (P = 1.43 × 10−10). Analysis of exome-sequencing data from a follow-up series of overgrowth probands identified a further pathogenic mutation, bringing the total number of affected individuals to 5. Heterozygotes shared similar phenotypic features including increased height, increased head circumference and intellectual disability. The mutations clustered within a region of nine amino acid residues in the aligned protein sequences (P = 1.6 × 10−5). We mapped the mutations onto the crystal structure of the PP2A holoenzyme complex to predict their molecular and functional consequences. These studies suggest that the mutations may affect substrate binding, thus perturbing the ability of PP2A to dephosphorylate particular protein substrates. PP2A is a major negative regulator of v-akt murine thymoma viral oncogene homolog 1 (AKT). Thus, our data further expand the list of genes encoding components of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT signalling cascade that are disrupted in human overgrowth conditions.Keywords
This publication has 14 references indexed in Scilit:
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancerCancer Letters, 2013
- When Overgrowth Bumps Into Cancer: The PTEN‐OpathiesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2013
- Molecular Mechanisms of Childhood OvergrowthAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2013
- Megalencephaly Syndromes and Activating Mutations in the PI3K‐AKT Pathway: MPPH and MCAPAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2013
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeNew England Journal of Medicine, 2011
- Presenting your structures: theCCP4mgmolecular-graphics softwareActa Crystallographica Section D Structural Biology, 2011
- Clk2 and B56β Mediate Insulin-Regulated Assembly of the PP2A Phosphatase Holoenzyme Complex on AktMolecular Cell, 2011
- Molecular Determinants for PP2A Substrate Specificity: Charged Residues Mediate Dephosphorylation of Tyrosine Hydroxylase by the PP2A/B′ Regulatory SubunitBiochemistry, 2009
- Structure and Function of the PP2A-Shugoshin InteractionMolecular Cell, 2009
- Inhibition of B56-containing Protein Phosphatase 2As by the Early Response Gene IEX-1 Leads to Control of Akt ActivityJournal of Biological Chemistry, 2007